Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New study shows estrogen patches lower cholesterol in men with prostate cancer

08.06.2004


Reduction is significant enough that it might lead to a reduction in the risk of heart disease caused by testosterone suppression

A small adhesive estrogen patch worn by men being treated for advanced prostate cancer lowers cholesterol, according to a new study conducted by Oregon Health & Science University Cancer Institute researchers.

This is important because men who have advanced prostate cancer are often treated with hormone deprivation therapy, which turns off testosterone to slow the growth of prostate cancer. Testosterone suppression is effective in controlling prostate cancer, but is associated with high cholesterol that may put men at greater risk for premature heart disease.



"Our data, while preliminary, suggest that estrogen skin patches counteract adverse effects of hormone therapy that raise cholesterol in men with prostate cancer," said Tomasz M. Beer, M.D., director of the Prostate Cancer Program in the OHSU Cancer Institute and principal investigator of the study.

"We found that transdermal estrogen decreased overall cholesterol levels by 10 percent. The effect was even greater on LDL cholesterol while HDL, the ’good cholesterol,’ was increased. Importantly, the patch estrogen did not cause triglyceride levels to rise, something that is common with oral estrogen preparations," Beer said.

Estrogen is known to induce testosterone suppression. Given orally, however, estrogen is associated with a high risk for blood clots that may involve both veins and arteries, and may include heart attacks. The OHSU group hypothesized that transdermal estrogen would be less likely to cause blood clots and preliminary analysis of their data support this premise.

"Given more study, estrogen skin patches may prove to be an alternative to common methods of hormone deprivation for prostate cancer as it provides testosterone suppression while improving cholesterol levels," Beer said.

In their study, Jonathan Q. Purnell, M.D., assistant professor of medicine (endocrinology, diabetes and clinical nutrition) in the OHSU School of Medicine, together with Beer and colleagues examined the effects of transdermal estrogen cholesterol and other lipids that have been associated with heart disease. The study was presented on June 7, 2004, at the American Society for Clinical Oncology annual meeting in New Orleans, La.

Eighteen androgen independent prostate cancer patients aged 49 to 92 participated in the study. They were treated with six 7.6 milligram (45.6 milligrams total) patches every seven days for eight weeks. Blood cholesterol and lipid levels were measured before and eight weeks after beginning transdermal estrogen therapy. Whole body composition and body fat also were measured.

"Transdermal estrogen increased protective cholesterols, decreased those associated with heart disease, and did not produce adverse effects seen with oral formulations of estrogen," Beer said. "While our results are promising, larger controlled studies are needed to determine the impact of transdermal estrogen therapy on cardiovascular risk."

Prostate cancer is the most common cancer in men and the second leading cause of cancer-related death in American men. Overall, one in six men will develop prostate cancer during his lifetime.


This study was funded in part by the National Cancer Institute, a component of the National Institutes of Health.

Particulars: ASCO Abstract No. 8035, Transdermal estrogen therapy improves cholesterol levels and lipid profiles in men with prostate cancer

Tomasz M. Beer, M.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and director of the Prostate Cancer Program in the OHSU Cancer Institute.

Rachel MacKnight | EurekAlert!
Further information:
http://www.ohsu.edu/
http://www.ohsu.edu/news/

More articles from Studies and Analyses:

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>